A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines

Influenza vaccines of H7N9 subtype are consistently less immunogenic in humans than vaccines developed for other subtypes. Although prior immunoinformatic analysis identified T-cell epitopes in H7 hemagglutinin (HA) which potentially enhance regulatory T cell response due to conservation with the hu...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 7; no. 1; pp. 1283 - 11
Main Authors Wada, Yamato, Nithichanon, Arnone, Nobusawa, Eri, Moise, Leonard, Martin, William D., Yamamoto, Norio, Terahara, Kazutaka, Hagiwara, Haruhisa, Odagiri, Takato, Tashiro, Masato, Lertmemongkolchai, Ganjana, Takeyama, Haruko, De Groot, Anne S., Ato, Manabu, Takahashi, Yoshimasa
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 28.04.2017
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Influenza vaccines of H7N9 subtype are consistently less immunogenic in humans than vaccines developed for other subtypes. Although prior immunoinformatic analysis identified T-cell epitopes in H7 hemagglutinin (HA) which potentially enhance regulatory T cell response due to conservation with the human genome, the links between the T-cell epitopes and low immunogenicity of H7 HA remains unknown due to the lack of animal models reproducing the response observed in humans. Here, we utilized a humanized mouse model to recapitulate the low immunogenicity of H7 HA. Our analysis demonstrated that modification of a single H7 epitope by changing 3 amino acids so that it is homologous with a known H3 immunogenic epitope sequence significantly improved the immunogenicity of the H7 HA in the humanized mouse model, leading to a greater than 4-fold increase in HA-binding IgG responses. Thus, we provide experimental evidence for the important contribution of this H7-specific T cell epitope in determining the immunogenicity of an influenza vaccine. Furthermore, this study delineates strategies that can be used for screening and selecting vaccine strains using immunoinformatics tools and a humanized mouse model.
AbstractList Influenza vaccines of H7N9 subtype are consistently less immunogenic in humans than vaccines developed for other subtypes. Although prior immunoinformatic analysis identified T-cell epitopes in H7 hemagglutinin (HA) which potentially enhance regulatory T cell response due to conservation with the human genome, the links between the T-cell epitopes and low immunogenicity of H7 HA remains unknown due to the lack of animal models reproducing the response observed in humans. Here, we utilized a humanized mouse model to recapitulate the low immunogenicity of H7 HA. Our analysis demonstrated that modification of a single H7 epitope by changing 3 amino acids so that it is homologous with a known H3 immunogenic epitope sequence significantly improved the immunogenicity of the H7 HA in the humanized mouse model, leading to a greater than 4-fold increase in HA-binding IgG responses. Thus, we provide experimental evidence for the important contribution of this H7-specific T cell epitope in determining the immunogenicity of an influenza vaccine. Furthermore, this study delineates strategies that can be used for screening and selecting vaccine strains using immunoinformatics tools and a humanized mouse model.
Influenza vaccines of H7N9 subtype are consistently less immunogenic in humans than vaccines developed for other subtypes. Although prior immunoinformatic analysis identified T-cell epitopes in H7 hemagglutinin (HA) which potentially enhance regulatory T cell response due to conservation with the human genome, the links between the T-cell epitopes and low immunogenicity of H7 HA remains unknown due to the lack of animal models reproducing the response observed in humans. Here, we utilized a humanized mouse model to recapitulate the low immunogenicity of H7 HA. Our analysis demonstrated that modification of a single H7 epitope by changing 3 amino acids so that it is homologous with a known H3 immunogenic epitope sequence significantly improved the immunogenicity of the H7 HA in the humanized mouse model, leading to a greater than 4-fold increase in HA-binding IgG responses. Thus, we provide experimental evidence for the important contribution of this H7-specific T cell epitope in determining the immunogenicity of an influenza vaccine. Furthermore, this study delineates strategies that can be used for screening and selecting vaccine strains using immunoinformatics tools and a humanized mouse model.Influenza vaccines of H7N9 subtype are consistently less immunogenic in humans than vaccines developed for other subtypes. Although prior immunoinformatic analysis identified T-cell epitopes in H7 hemagglutinin (HA) which potentially enhance regulatory T cell response due to conservation with the human genome, the links between the T-cell epitopes and low immunogenicity of H7 HA remains unknown due to the lack of animal models reproducing the response observed in humans. Here, we utilized a humanized mouse model to recapitulate the low immunogenicity of H7 HA. Our analysis demonstrated that modification of a single H7 epitope by changing 3 amino acids so that it is homologous with a known H3 immunogenic epitope sequence significantly improved the immunogenicity of the H7 HA in the humanized mouse model, leading to a greater than 4-fold increase in HA-binding IgG responses. Thus, we provide experimental evidence for the important contribution of this H7-specific T cell epitope in determining the immunogenicity of an influenza vaccine. Furthermore, this study delineates strategies that can be used for screening and selecting vaccine strains using immunoinformatics tools and a humanized mouse model.
Abstract Influenza vaccines of H7N9 subtype are consistently less immunogenic in humans than vaccines developed for other subtypes. Although prior immunoinformatic analysis identified T-cell epitopes in H7 hemagglutinin (HA) which potentially enhance regulatory T cell response due to conservation with the human genome, the links between the T-cell epitopes and low immunogenicity of H7 HA remains unknown due to the lack of animal models reproducing the response observed in humans. Here, we utilized a humanized mouse model to recapitulate the low immunogenicity of H7 HA. Our analysis demonstrated that modification of a single H7 epitope by changing 3 amino acids so that it is homologous with a known H3 immunogenic epitope sequence significantly improved the immunogenicity of the H7 HA in the humanized mouse model, leading to a greater than 4-fold increase in HA-binding IgG responses. Thus, we provide experimental evidence for the important contribution of this H7-specific T cell epitope in determining the immunogenicity of an influenza vaccine. Furthermore, this study delineates strategies that can be used for screening and selecting vaccine strains using immunoinformatics tools and a humanized mouse model.
ArticleNumber 1283
Author De Groot, Anne S.
Nithichanon, Arnone
Terahara, Kazutaka
Ato, Manabu
Martin, William D.
Lertmemongkolchai, Ganjana
Takeyama, Haruko
Moise, Leonard
Hagiwara, Haruhisa
Odagiri, Takato
Takahashi, Yoshimasa
Nobusawa, Eri
Wada, Yamato
Yamamoto, Norio
Tashiro, Masato
Author_xml – sequence: 1
  givenname: Yamato
  surname: Wada
  fullname: Wada, Yamato
  organization: Department of Immunology, National Institute of Infectious Diseases, Department of Life Science and Medical Bioscience, Waseda University
– sequence: 2
  givenname: Arnone
  surname: Nithichanon
  fullname: Nithichanon, Arnone
  organization: Department of Immunology, National Institute of Infectious Diseases, Center for Research and Development of Medical Diagnostic Laboratories (CMDL), Faculty of Associated Medical Sciences, Khon Kaen University
– sequence: 3
  givenname: Eri
  surname: Nobusawa
  fullname: Nobusawa, Eri
  organization: Influenza Virus Research Center, National Institute of Infectious Diseases
– sequence: 4
  givenname: Leonard
  surname: Moise
  fullname: Moise, Leonard
  organization: Institute for Immunology and Informatics, University of Rhode Island, EpiVax Inc
– sequence: 5
  givenname: William D.
  surname: Martin
  fullname: Martin, William D.
  organization: EpiVax Inc
– sequence: 6
  givenname: Norio
  surname: Yamamoto
  fullname: Yamamoto, Norio
  organization: Influenza Virus Research Center, National Institute of Infectious Diseases, Department of Infection Control Science, Graduate School of Medicine, Juntendo University
– sequence: 7
  givenname: Kazutaka
  surname: Terahara
  fullname: Terahara, Kazutaka
  organization: Department of Immunology, National Institute of Infectious Diseases
– sequence: 8
  givenname: Haruhisa
  surname: Hagiwara
  fullname: Hagiwara, Haruhisa
  organization: Hagiwara Clinic
– sequence: 9
  givenname: Takato
  surname: Odagiri
  fullname: Odagiri, Takato
  organization: Influenza Virus Research Center, National Institute of Infectious Diseases
– sequence: 10
  givenname: Masato
  orcidid: 0000-0001-8133-1263
  surname: Tashiro
  fullname: Tashiro, Masato
  organization: Influenza Virus Research Center, National Institute of Infectious Diseases
– sequence: 11
  givenname: Ganjana
  surname: Lertmemongkolchai
  fullname: Lertmemongkolchai, Ganjana
  organization: Center for Research and Development of Medical Diagnostic Laboratories (CMDL), Faculty of Associated Medical Sciences, Khon Kaen University
– sequence: 12
  givenname: Haruko
  surname: Takeyama
  fullname: Takeyama, Haruko
  organization: Department of Life Science and Medical Bioscience, Waseda University
– sequence: 13
  givenname: Anne S.
  surname: De Groot
  fullname: De Groot, Anne S.
  organization: Institute for Immunology and Informatics, University of Rhode Island, EpiVax Inc
– sequence: 14
  givenname: Manabu
  surname: Ato
  fullname: Ato, Manabu
  organization: Department of Immunology, National Institute of Infectious Diseases
– sequence: 15
  givenname: Yoshimasa
  surname: Takahashi
  fullname: Takahashi, Yoshimasa
  email: ytakahas@niid.go.jp
  organization: Department of Immunology, National Institute of Infectious Diseases
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28455520$$D View this record in MEDLINE/PubMed
BookMark eNp9UsFuFSEUnZgaW2t_wIUhceNmFBgYYGPSNNY2aXSjGzeEgcsrzxmoMFPz_PrSvta8NlESuATOOTm597xs9mKK0DSvCX5PcCc_FEa4ki0mou5O0JY_aw4oZrylHaV7O_f95qiUNa6LU8WIetHsU8k45xQfND-O0eUymRj-gENTWgrU08GIgoM4Bx-goJ-wQWYKMSFjgyvIp4zG9BuFaVpiWkEMNswblDw6E18UujbWhgjlVfPcm7HA0X09bL6ffvp2ctZefP18fnJ80VrO8Nx6orBX1gsQDqz3SlgCkhkHph-MZMJRZgYzUOo5F0IKTo3CtjcDEwNXojtszre6Lpm1vsphMnmjkwn67iHllTZ5DnYEzRV12IPlnZVMMjsoyqzxHKDnVPK-an3cal0twwTO1h5kMz4SffwTw6VepWvNWYdl31WBd_cCOf1aoMx6CsXCOJoItbuaSNVxpvpeVejbJ9B1WnKsrdJE9UQSghWpqDe7jv5aeRhhBcgtwOZUSgav6zTMHNKtwTBqgvVtYPQ2MLoGRt8FRvNKpU-oD-r_JXVbUqnguIK8Y_vfrBsdzdLc
CitedBy_id crossref_primary_10_1016_j_ymthe_2020_11_027
crossref_primary_10_3389_fimmu_2024_1474346
crossref_primary_10_1371_journal_ppat_1011554
crossref_primary_10_1038_s41467_019_11821_6
crossref_primary_10_1016_j_csbj_2020_12_039
crossref_primary_10_3389_fimmu_2019_02274
crossref_primary_10_3389_fimmu_2020_00442
crossref_primary_10_1016_j_biopha_2024_116983
crossref_primary_10_1038_s41467_020_14579_4
crossref_primary_10_1016_j_vaccine_2023_06_019
crossref_primary_10_1038_s41598_021_89016_7
crossref_primary_10_1080_14760584_2024_2303015
crossref_primary_10_1016_j_vaccine_2019_07_033
crossref_primary_10_1080_14760584_2022_2012456
crossref_primary_10_1208_s12248_023_00852_z
crossref_primary_10_1080_21645515_2020_1793711
crossref_primary_10_3390_v11030252
crossref_primary_10_1080_22221751_2025_2467770
crossref_primary_10_1093_intimm_dxy069
crossref_primary_10_1093_bib_bbac190
crossref_primary_10_1080_21645515_2019_1703453
crossref_primary_10_18632_oncotarget_25399
crossref_primary_10_3389_fimmu_2023_1247876
crossref_primary_10_1080_21645515_2018_1495303
crossref_primary_10_1016_j_clim_2020_108661
crossref_primary_10_1111_imm_12816
crossref_primary_10_3389_fimmu_2021_690348
crossref_primary_10_1002_ame2_12449
crossref_primary_10_3390_v11030300
crossref_primary_10_1002_advs_201800494
crossref_primary_10_1016_j_celrep_2024_114259
crossref_primary_10_3389_fmicb_2017_01898
crossref_primary_10_3390_v13061011
Cites_doi 10.1172/JCI32460
10.4049/jimmunol.181.8.5306
10.1038/44385
10.2807/1560-7917.ES2014.19.25.20838
10.1038/289373a0
10.1016/j.cimid.2010.02.006
10.1182/blood-2009-08-239145
10.1001/jama.2014.12854
10.1128/JVI.02226-09
10.1080/21645515.2015.1052197
10.1056/NEJMoa0908535
10.1016/s0140-6736(06)68656-x
10.1007/978-3-540-92165-3_3
10.1016/s0140-6736(09)62026-2
10.1186/1471-2105-15-s4-s1
10.4161/hv.24615
10.1084/jem.20142284
10.4049/jimmunol.1001395
10.1073/pnas.1115369109
10.1056/NEJMoa1006736
10.4049/jimmunol.1600046
10.1128/jcm.42.4.1782-1784.2004
10.1084/jem.164.4.1114
10.1586/14760584.2016.1123098
10.1126/scitranslmed.3008761
10.1111/j.1600-065X.2010.00939.x
10.4161/hv.25598
10.4161/hv.28135
10.1128/CVI.00272-14
10.1016/j.tim.2014.08.008
10.1086/598954
10.1146/annurev.biochem.69.1.531
10.1080/21645515.2015.1061159
10.1007/s12185-008-0215-z
10.1038/nm.2612
10.1056/NEJMoa0907413
10.1016/j.vaccine.2010.10.077
10.1016/s0140-6736(99)01241-6
10.1182/blood-2012-07-409755
10.1056/NEJMc1313186
10.1093/infdis/jis684
10.4049/jimmunol.180.3.1758
10.1093/infdis/jiu662
10.1056/NEJMoa055778
10.1016/s0140-6736(09)62003-1
10.1371/journal.pone.0049704
10.1016/j.jhep.2014.08.026
10.3201/eid2002.131094
10.1073/pnas.0911580106
ContentType Journal Article
Copyright The Author(s) 2017
2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2017
– notice: 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.1038/s41598-017-01372-5
DatabaseName Springer Nature Link
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central (New)
Natural Science Collection
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
MEDLINE - Academic

MEDLINE
CrossRef


Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature Link
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 11
ExternalDocumentID oai_doaj_org_article_592d0fec53c8484cb924caf5ee652856
PMC5430863
28455520
10_1038_s41598_017_01372_5
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
EJD
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AARCD
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c540t-f190f9cf7e7decff97c1e84adea6ba847d24abab22f55778752a90c6ab47b5973
IEDL.DBID M48
ISSN 2045-2322
IngestDate Wed Aug 27 01:21:55 EDT 2025
Thu Aug 21 14:37:26 EDT 2025
Thu Jul 10 19:11:26 EDT 2025
Wed Aug 13 10:57:05 EDT 2025
Wed Feb 19 02:43:11 EST 2025
Tue Jul 01 01:32:51 EDT 2025
Thu Apr 24 23:03:36 EDT 2025
Fri Feb 21 02:40:08 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c540t-f190f9cf7e7decff97c1e84adea6ba847d24abab22f55778752a90c6ab47b5973
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-8133-1263
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-017-01372-5
PMID 28455520
PQID 1961811091
PQPubID 2041939
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_592d0fec53c8484cb924caf5ee652856
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5430863
proquest_miscellaneous_1893549669
proquest_journals_1961811091
pubmed_primary_28455520
crossref_citationtrail_10_1038_s41598_017_01372_5
crossref_primary_10_1038_s41598_017_01372_5
springer_journals_10_1038_s41598_017_01372_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-04-28
PublicationDateYYYYMMDD 2017-04-28
PublicationDate_xml – month: 04
  year: 2017
  text: 2017-04-28
  day: 28
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2017
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References LiuRH7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated toleranceHum Vaccin Immunother2015112241225210.1080/21645515.2015.1052197260905774635734
HeLIntegrated assessment of predicted MHC binding and cross-conservation with self reveals patterns of viral camouflageBMC bioinformatics201415Suppl 4S12014AIPC.1601....1H10.1186/1471-2105-15-s4-s1251042214094998
ScherlePAGerhardWFunctional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutininJ Exp Med1986164111411281:CAS:528:DyaL28XlvV2jtLw%3D10.1084/jem.164.4.11142944982
PlennevauxESheldonEBlatterMReeves-HocheMKDenisMImmune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trialsLancet201037541481:CAS:528:DC%2BC3cXotl2j10.1016/s0140-6736(09)62026-220018365
GreenbaumJAPre-existing immunity against swine-origin H1N1 influenza viruses in the general human populationProc Natl Acad Sci USA200910620365203702009PNAS..10620365G10.1073/pnas.0911580106199180652777968
WuJSafety and effectiveness of a 2009 H1N1 vaccine in BeijingN Engl J Med2010363241624231:CAS:528:DC%2BC3cXhsF2ltb7N10.1056/NEJMoa100673621158658
ChevalierMFWeissLThe split personality of regulatory T cells in HIV infectionBlood201312129371:CAS:528:DC%2BC3sXps1eruw%3D%3D10.1182/blood-2012-07-40975523043072
CoxNJSubbaraoKInfluenzaLancet1999354127712821:STN:280:DyaK1MvkvV2mug%3D%3D10.1016/s0140-6736(99)01241-610520648
GreenbergMEResponse to a monovalent 2009 influenza A (H1N1) vaccineN Engl J Med2009361240524131:CAS:528:DC%2BD1MXhsFKisr7P10.1056/NEJMoa090741319745216
RichardsKASeasonal influenza can poise hosts for CD4 T-cell immunity to H7N9 avian influenzaJ Infect Dis201521286941:CAS:528:DC%2BC1cXjs1Wr10.1093/infdis/jiu66225492919
OkadaSHaradaHItoTSaitoTSuzuSEarly development of human hematopoietic and acquired immune systems in new born NOD/Scid/Jak3null mice intrahepatic engrafted with cord blood-derived CD34+ cellsInt J Hematol20088847648210.1007/s12185-008-0215-z19039627
BressonJ-LSafety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trialLancet2006367165716641:CAS:528:DC%2BD28XkvVCks74%3D10.1016/s0140-6736(06)68656-x16714186
MoiseLUniversal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011Hum Vaccin Immunother20139159816071:CAS:528:DC%2BC2cXls1SgtQ%3D%3D10.4161/hv.2559823846304
KurosakiTAibaYKometaniKMoriyamaSTakahashiYUnique properties of memory B cells of different isotypesImmunol Rev20102371041161:CAS:528:DC%2BC3cXhtFKrtbzN10.1111/j.1600-065X.2010.00939.x20727032
TakahashiYProtective immunity afforded by inactivated H5N1 (NIBRG-14) vaccine requires antibodies against both hemagglutinin and neuraminidase in miceJ Infect Dis2009199162916371:CAS:528:DC%2BD1MXmvVOmur4%3D10.1086/59895419385735
LeeLYMemory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individualsJ Clin Invest20081183478349010.1172/JCI32460188024962542885
de SouzaVAUFUse of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infectionsJ Clin Microbiol2004421782178410.1128/jcm.42.4.1782-1784.200415071049387572
HuJZhuYZhaoBLiJLiuLGuKZhangWSuHTengZTangSYuanZFengZWuFLimited human-to-human transmission of avian influenza A(H7N9) virus, Shanghai, China, March to April 2013Eurosurveillance201419252083810.2807/1560-7917.ES2014.19.25.2083824993556
KrammerFAn H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humansClin Vaccine Immunol201421115311631:CAS:528:DC%2BC2cXhs1emurjJ10.1128/CVI.00272-14249433834135918
MoiseLiVAX: an integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccinesHum Vaccin Immunother2015112312232110.1080/21645515.2015.1061159261559594635942
TreanorJJCampbellJDZangwillKMRoweTWolffMSafety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccineN Engl J Med2006354134313511:CAS:528:DC%2BD28XjtVCju7k%3D10.1056/NEJMoa05577816571878
GuoLHuman antibody responses to avian influenza A(H7N9) virus, 2013Emerg Infect Dis20142019220010.3201/eid2002.131094244474233901473
MoiseLT cell epitope redundancy: cross-conservation of the TCR face between pathogens and self and its implications for vaccines and autoimmunityExpert Rev Vaccines2016156076171:CAS:528:DC%2BC28XisFKgurY%3D10.1586/14760584.2016.112309826588466
OnoderaTMemory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfectionProc Natl Acad Sci USA2012109248524902012PNAS..109.2485O10.1073/pnas.1115369109223083863289300
SallustoFLenigDForsterRLippMLanzavecchiaATwo subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature19994017087121999Natur.401..708S1:CAS:528:DyaK1MXntVWntrw%3D10.1038/4438510537110
WatanabeTWatanabeSMaherEANeumannGKawaokaYPandemic potential of avian influenza A (H7N9) virusesTrends Microbiol2014226236311:CAS:528:DC%2BC2cXhsV2ktrvO10.1016/j.tim.2014.08.008252643124252989
RichardsKATophamDChavesFASantAJCutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virusJ Immunol2010185499850021:CAS:528:DC%2BC3cXhtlWhsr7P10.4049/jimmunol.100139520889549
RotiMHealthy human subjects have CD4+ T cells directed against H5N1 influenza virusJ Immunol2008180175817681:CAS:528:DC%2BD1cXotlKhsw%3D%3D10.4049/jimmunol.180.3.175818209073
SubbramanianRABashaSShataMTBradyRCBernsteinDIPandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccinationVaccine201028825882671:CAS:528:DC%2BC3cXhsFWqtbfM10.1016/j.vaccine.2010.10.07721050903
MoiseLThe two-faced T cell epitope: examining the host-microbe interface with JanusMatrixHum Vaccin Immunother20139157715861:CAS:528:DC%2BC2cXls1SgsQ%3D%3D10.4161/hv.24615235842513974887
LosikoffPTHCV epitope, homologous to multiple human protein sequences, induces a regulatory T cell response in infected patientsJ Hepatol20156248551:CAS:528:DC%2BC2cXhslyksLbP10.1016/j.jhep.2014.08.02625157982
NayakJLCD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccineJ Infect Dis20132072973051:CAS:528:DC%2BC3sXktFCquw%3D%3D10.1093/infdis/jis68423148285
FioreAEBridgesCBCoxNJSeasonal influenza vaccinesCurr Top Microbiol Immunol200933343821:CAS:528:DC%2BC3cXitFCru7w%3D10.1007/978-3-540-92165-3_319768400
GeXAssessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virusJ Virol201084331233191:CAS:528:DC%2BC3cXktFOgtr0%3D10.1128/JVI.02226-09200715642838145
CouchRBPatelSMWade-BowersCLNinoDA randomized clinical trial of an inactivated avian influenza A (H7N7) vaccinePLoS One20127e497042012PLoSO...749704C1:CAS:528:DC%2BC38XhvFSks7bF10.1371/journal.pone.0049704232399683519847
WileyDCWilsonIASkehelJJStructural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variationNature19812893733781981Natur.289..373W1:CAS:528:DyaL3MXhvFSjtbw%3D10.1038/289373a06162101
Bart, S. A. et al. A cell culture-derived MF59-adjuvanted pandemic A/H7N9 vaccine is immunogenic in adults. Sci Transl Med6, 234ra255, doi:10.1126/scitranslmed.3008761 (2014).
AdachiYDistinct germinal center selection at local sites shapes memory B cell response to viral escapeJ Exp Med2015212170917231:CAS:528:DC%2BC28Xht12jurs%3D10.1084/jem.20142284263244444577849
LiangXFSafety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trialLancet201037556661:CAS:528:DC%2BC3cXotl2h10.1016/s0140-6736(09)62003-120018364
ShawJWangYHItoTArimaKLiuYJPlasmacytoid dendritic cells regulate B-cell growth and differentiation via CD70Blood2010115305130571:CAS:528:DC%2BC3cXltlWru7s%3D10.1182/blood-2009-08-239145201390962858470
ZhuFCA novel influenza A (H1N1) vaccine in various age groupsN Engl J Med2009361241424231:CAS:528:DC%2BD1MXhsFKisr7I10.1056/NEJMoa090853519846844
De GrootASCross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine designHum Vaccin Immunother2014102562621:CAS:528:DC%2BC2cXhsFCisrzK10.4161/hv.28135245256184185886
SkehelJJWileyDCReceptor binding and membrane fusion in virus entry: the influenza hemagglutininAnnu Rev Biochem2000695315691:CAS:528:DC%2BD3cXnt1ajtbY%3D10.1146/annurev.biochem.69.1.53110966468
MoensLWuytsMMeytsIDe BoeckKBossuytXHuman memory B lymphocyte subsets fulfill distinct roles in the anti-polysaccharide and anti-protein immune responseJ Immunol2008181530653121:CAS:528:DC%2BD1cXhtF2hs7bN10.4049/jimmunol.181.8.530618832686
SatohMEvaluation of a recombinant measles virus expressing hepatitis C virus envelope proteins by infection of human PBL-NOD/Scid/Jak3null mouseComp Immunol Microbiol Infect Dis201033e818810.1016/j.cimid.2010.02.006202990977112578
OnoderaTWhole-virion influenza vaccine recalls an early burst of high-affinity memory B cell response through TLR signalingJ Immunol2016196417241841:CAS:528:DC%2BC28XntlCnurw%3D10.4049/jimmunol.160004627053762
WilkinsonTMPreexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humansNat Med2012182742801:CAS:528:DC%2BC38XhtlOlt7c%3D10.1038/nm.261222286307
MulliganMJSerological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trialJAMA2014312140914191:CAS:528:DC%2BC2cXhvFSltbnP10.1001/jama.2014.1285425291577
World Health Organization Influenza (Seasonal), http://w
KA Richards (1372_CR13) 2010; 185
R Liu (1372_CR28) 2015; 11
J Hu (1372_CR43) 2014; 19
1372_CR33
JJ Treanor (1372_CR22) 2006; 354
J-L Bresson (1372_CR21) 2006; 367
LF Fries (1372_CR32) 2013; 369
JJ Skehel (1372_CR4) 2000; 69
FC Zhu (1372_CR10) 2009; 361
MF Chevalier (1372_CR39) 2013; 121
L Moens (1372_CR35) 2008; 181
DC Wiley (1372_CR3) 1981; 289
NJ Cox (1372_CR2) 1999; 354
X Ge (1372_CR14) 2010; 84
RA Subbramanian (1372_CR15) 2010; 28
MJ Mulligan (1372_CR23) 2014; 312
T Kurosaki (1372_CR36) 2010; 237
S Okada (1372_CR29) 2008; 88
L Moise (1372_CR46) 2013; 9
TM Wilkinson (1372_CR17) 2012; 18
KA Richards (1372_CR20) 2015; 212
RB Couch (1372_CR26) 2012; 7
L Moise (1372_CR47) 2013; 9
T Onodera (1372_CR6) 2016; 196
M Satoh (1372_CR30) 2010; 33
E Plennevaux (1372_CR9) 2010; 375
J Shaw (1372_CR38) 2010; 115
T Onodera (1372_CR50) 2012; 109
Y Adachi (1372_CR49) 2015; 212
M Roti (1372_CR19) 2008; 180
XF Liang (1372_CR8) 2010; 375
LY Lee (1372_CR18) 2008; 118
L Moise (1372_CR40) 2016; 15
AE Fiore (1372_CR5) 2009; 333
PA Scherle (1372_CR34) 1986; 164
F Krammer (1372_CR25) 2014; 21
L He (1372_CR41) 2014; 15
ME Greenberg (1372_CR7) 2009; 361
JA Greenbaum (1372_CR12) 2009; 106
1372_CR1
AS De Groot (1372_CR27) 2014; 10
L Guo (1372_CR24) 2014; 20
VAUF de Souza (1372_CR31) 2004; 42
F Sallusto (1372_CR37) 1999; 401
Y Takahashi (1372_CR48) 2009; 199
J Wu (1372_CR11) 2010; 363
JL Nayak (1372_CR16) 2013; 207
T Watanabe (1372_CR44) 2014; 22
L Moise (1372_CR45) 2015; 11
PT Losikoff (1372_CR42) 2015; 62
20018365 - Lancet. 2010 Jan 2;375(9708):41-8
18802496 - J Clin Invest. 2008 Oct;118(10 ):3478-90
24447423 - Emerg Infect Dis. 2014 Feb;20(2):192-200
2944982 - J Exp Med. 1986 Oct 1;164(4):1114-28
24943383 - Clin Vaccine Immunol. 2014 Aug;21(8):1153-63
20727032 - Immunol Rev. 2010 Sep;237(1):104-16
22308386 - Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2485-90
18209073 - J Immunol. 2008 Feb 1;180(3):1758-68
27053762 - J Immunol. 2016 May 15;196(10):4172-84
23148285 - J Infect Dis. 2013 Jan 15;207(2):297-305
10520648 - Lancet. 1999 Oct 9;354(9186):1277-82
20889549 - J Immunol. 2010 Nov 1;185(9):4998-5002
24786323 - Sci Transl Med. 2014 Apr 30;6(234):234ra55
16571878 - N Engl J Med. 2006 Mar 30;354(13):1343-51
16714186 - Lancet. 2006 May 20;367(9523):1657-64
20018364 - Lancet. 2010 Jan 2;375(9708):56-66
26588466 - Expert Rev Vaccines. 2016 May;15(5):607-17
23584251 - Hum Vaccin Immunother. 2013 Jul;9(7):1577-86
21158658 - N Engl J Med. 2010 Dec 16;363(25):2416-23
21050903 - Vaccine. 2010 Dec 6;28(52):8258-67
25104221 - BMC Bioinformatics. 2014;15 Suppl 4:S1
20139096 - Blood. 2010 Apr 15;115(15):3051-7
25264312 - Trends Microbiol. 2014 Nov;22(11):623-31
19768400 - Curr Top Microbiol Immunol. 2009;333:43-82
20071564 - J Virol. 2010 Apr;84(7):3312-9
23846304 - Hum Vaccin Immunother. 2013 Jul;9(7):1598-607
18832686 - J Immunol. 2008 Oct 15;181(8):5306-12
23239968 - PLoS One. 2012;7(12):e49704
15071049 - J Clin Microbiol. 2004 Apr;42(4):1782-4
19039627 - Int J Hematol. 2008 Dec;88(5):476-82
10537110 - Nature. 1999 Oct 14;401(6754):708-12
19745216 - N Engl J Med. 2009 Dec 17;361(25):2405-13
6162101 - Nature. 1981 Jan 29;289(5796):373-8
24993556 - Euro Surveill. 2014 Jun 26;19(25):null
25157982 - J Hepatol. 2015 Jan;62(1):48-55
19918065 - Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20365-70
10966468 - Annu Rev Biochem. 2000;69:531-69
23043072 - Blood. 2013 Jan 3;121(1):29-37
22286307 - Nat Med. 2012 Jan 29;18(2):274-80
20299097 - Comp Immunol Microbiol Infect Dis. 2010 Dec;33(6):e81-8
25492919 - J Infect Dis. 2015 Jul 1;212(1):86-94
19385735 - J Infect Dis. 2009 Jun 1;199(11):1629-37
26324444 - J Exp Med. 2015 Sep 21;212(10):1709-23
25291577 - JAMA. 2014 Oct 8;312(14):1409-19
19846844 - N Engl J Med. 2009 Dec 17;361(25):2414-23
26155959 - Hum Vaccin Immunother. 2015;11(9):2312-21
26090577 - Hum Vaccin Immunother. 2015;11(9):2241-52
24224560 - N Engl J Med. 2013 Dec 26;369(26):2564-6
24525618 - Hum Vaccin Immunother. 2014;10(2):256-62
References_xml – reference: OnoderaTWhole-virion influenza vaccine recalls an early burst of high-affinity memory B cell response through TLR signalingJ Immunol2016196417241841:CAS:528:DC%2BC28XntlCnurw%3D10.4049/jimmunol.160004627053762
– reference: WileyDCWilsonIASkehelJJStructural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variationNature19812893733781981Natur.289..373W1:CAS:528:DyaL3MXhvFSjtbw%3D10.1038/289373a06162101
– reference: KurosakiTAibaYKometaniKMoriyamaSTakahashiYUnique properties of memory B cells of different isotypesImmunol Rev20102371041161:CAS:528:DC%2BC3cXhtFKrtbzN10.1111/j.1600-065X.2010.00939.x20727032
– reference: De GrootASCross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine designHum Vaccin Immunother2014102562621:CAS:528:DC%2BC2cXhsFCisrzK10.4161/hv.28135245256184185886
– reference: LosikoffPTHCV epitope, homologous to multiple human protein sequences, induces a regulatory T cell response in infected patientsJ Hepatol20156248551:CAS:528:DC%2BC2cXhslyksLbP10.1016/j.jhep.2014.08.02625157982
– reference: AdachiYDistinct germinal center selection at local sites shapes memory B cell response to viral escapeJ Exp Med2015212170917231:CAS:528:DC%2BC28Xht12jurs%3D10.1084/jem.20142284263244444577849
– reference: RichardsKATophamDChavesFASantAJCutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virusJ Immunol2010185499850021:CAS:528:DC%2BC3cXhtlWhsr7P10.4049/jimmunol.100139520889549
– reference: World Health Organization Influenza (Seasonal), http://www.who.int/mediacentre/factsheets/fs211/en/ (2014).
– reference: SallustoFLenigDForsterRLippMLanzavecchiaATwo subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature19994017087121999Natur.401..708S1:CAS:528:DyaK1MXntVWntrw%3D10.1038/4438510537110
– reference: WatanabeTWatanabeSMaherEANeumannGKawaokaYPandemic potential of avian influenza A (H7N9) virusesTrends Microbiol2014226236311:CAS:528:DC%2BC2cXhsV2ktrvO10.1016/j.tim.2014.08.008252643124252989
– reference: SatohMEvaluation of a recombinant measles virus expressing hepatitis C virus envelope proteins by infection of human PBL-NOD/Scid/Jak3null mouseComp Immunol Microbiol Infect Dis201033e818810.1016/j.cimid.2010.02.006202990977112578
– reference: CoxNJSubbaraoKInfluenzaLancet1999354127712821:STN:280:DyaK1MvkvV2mug%3D%3D10.1016/s0140-6736(99)01241-610520648
– reference: KrammerFAn H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humansClin Vaccine Immunol201421115311631:CAS:528:DC%2BC2cXhs1emurjJ10.1128/CVI.00272-14249433834135918
– reference: BressonJ-LSafety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trialLancet2006367165716641:CAS:528:DC%2BD28XkvVCks74%3D10.1016/s0140-6736(06)68656-x16714186
– reference: HeLIntegrated assessment of predicted MHC binding and cross-conservation with self reveals patterns of viral camouflageBMC bioinformatics201415Suppl 4S12014AIPC.1601....1H10.1186/1471-2105-15-s4-s1251042214094998
– reference: SkehelJJWileyDCReceptor binding and membrane fusion in virus entry: the influenza hemagglutininAnnu Rev Biochem2000695315691:CAS:528:DC%2BD3cXnt1ajtbY%3D10.1146/annurev.biochem.69.1.53110966468
– reference: GreenbaumJAPre-existing immunity against swine-origin H1N1 influenza viruses in the general human populationProc Natl Acad Sci USA200910620365203702009PNAS..10620365G10.1073/pnas.0911580106199180652777968
– reference: MoiseLThe two-faced T cell epitope: examining the host-microbe interface with JanusMatrixHum Vaccin Immunother20139157715861:CAS:528:DC%2BC2cXls1SgsQ%3D%3D10.4161/hv.24615235842513974887
– reference: GuoLHuman antibody responses to avian influenza A(H7N9) virus, 2013Emerg Infect Dis20142019220010.3201/eid2002.131094244474233901473
– reference: NayakJLCD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccineJ Infect Dis20132072973051:CAS:528:DC%2BC3sXktFCquw%3D%3D10.1093/infdis/jis68423148285
– reference: HuJZhuYZhaoBLiJLiuLGuKZhangWSuHTengZTangSYuanZFengZWuFLimited human-to-human transmission of avian influenza A(H7N9) virus, Shanghai, China, March to April 2013Eurosurveillance201419252083810.2807/1560-7917.ES2014.19.25.2083824993556
– reference: RotiMHealthy human subjects have CD4+ T cells directed against H5N1 influenza virusJ Immunol2008180175817681:CAS:528:DC%2BD1cXotlKhsw%3D%3D10.4049/jimmunol.180.3.175818209073
– reference: MoensLWuytsMMeytsIDe BoeckKBossuytXHuman memory B lymphocyte subsets fulfill distinct roles in the anti-polysaccharide and anti-protein immune responseJ Immunol2008181530653121:CAS:528:DC%2BD1cXhtF2hs7bN10.4049/jimmunol.181.8.530618832686
– reference: FriesLFSmithGEGlennGMA recombinant viruslike particle influenza A (H7N9) vaccineN Engl J Med2013369256425661:CAS:528:DC%2BC2cXhsl2gurk%3D10.1056/NEJMc131318624224560
– reference: ShawJWangYHItoTArimaKLiuYJPlasmacytoid dendritic cells regulate B-cell growth and differentiation via CD70Blood2010115305130571:CAS:528:DC%2BC3cXltlWru7s%3D10.1182/blood-2009-08-239145201390962858470
– reference: OnoderaTMemory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfectionProc Natl Acad Sci USA2012109248524902012PNAS..109.2485O10.1073/pnas.1115369109223083863289300
– reference: CouchRBPatelSMWade-BowersCLNinoDA randomized clinical trial of an inactivated avian influenza A (H7N7) vaccinePLoS One20127e497042012PLoSO...749704C1:CAS:528:DC%2BC38XhvFSks7bF10.1371/journal.pone.0049704232399683519847
– reference: PlennevauxESheldonEBlatterMReeves-HocheMKDenisMImmune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trialsLancet201037541481:CAS:528:DC%2BC3cXotl2j10.1016/s0140-6736(09)62026-220018365
– reference: TreanorJJCampbellJDZangwillKMRoweTWolffMSafety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccineN Engl J Med2006354134313511:CAS:528:DC%2BD28XjtVCju7k%3D10.1056/NEJMoa05577816571878
– reference: ZhuFCA novel influenza A (H1N1) vaccine in various age groupsN Engl J Med2009361241424231:CAS:528:DC%2BD1MXhsFKisr7I10.1056/NEJMoa090853519846844
– reference: LiuRH7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated toleranceHum Vaccin Immunother2015112241225210.1080/21645515.2015.1052197260905774635734
– reference: OkadaSHaradaHItoTSaitoTSuzuSEarly development of human hematopoietic and acquired immune systems in new born NOD/Scid/Jak3null mice intrahepatic engrafted with cord blood-derived CD34+ cellsInt J Hematol20088847648210.1007/s12185-008-0215-z19039627
– reference: RichardsKASeasonal influenza can poise hosts for CD4 T-cell immunity to H7N9 avian influenzaJ Infect Dis201521286941:CAS:528:DC%2BC1cXjs1Wr10.1093/infdis/jiu66225492919
– reference: de SouzaVAUFUse of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infectionsJ Clin Microbiol2004421782178410.1128/jcm.42.4.1782-1784.200415071049387572
– reference: ChevalierMFWeissLThe split personality of regulatory T cells in HIV infectionBlood201312129371:CAS:528:DC%2BC3sXps1eruw%3D%3D10.1182/blood-2012-07-40975523043072
– reference: LiangXFSafety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trialLancet201037556661:CAS:528:DC%2BC3cXotl2h10.1016/s0140-6736(09)62003-120018364
– reference: WilkinsonTMPreexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humansNat Med2012182742801:CAS:528:DC%2BC38XhtlOlt7c%3D10.1038/nm.261222286307
– reference: SubbramanianRABashaSShataMTBradyRCBernsteinDIPandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccinationVaccine201028825882671:CAS:528:DC%2BC3cXhsFWqtbfM10.1016/j.vaccine.2010.10.07721050903
– reference: MoiseLiVAX: an integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccinesHum Vaccin Immunother2015112312232110.1080/21645515.2015.1061159261559594635942
– reference: GeXAssessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virusJ Virol201084331233191:CAS:528:DC%2BC3cXktFOgtr0%3D10.1128/JVI.02226-09200715642838145
– reference: Bart, S. A. et al. A cell culture-derived MF59-adjuvanted pandemic A/H7N9 vaccine is immunogenic in adults. Sci Transl Med6, 234ra255, doi:10.1126/scitranslmed.3008761 (2014).
– reference: FioreAEBridgesCBCoxNJSeasonal influenza vaccinesCurr Top Microbiol Immunol200933343821:CAS:528:DC%2BC3cXitFCru7w%3D10.1007/978-3-540-92165-3_319768400
– reference: MulliganMJSerological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trialJAMA2014312140914191:CAS:528:DC%2BC2cXhvFSltbnP10.1001/jama.2014.1285425291577
– reference: MoiseLUniversal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011Hum Vaccin Immunother20139159816071:CAS:528:DC%2BC2cXls1SgtQ%3D%3D10.4161/hv.2559823846304
– reference: LeeLYMemory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individualsJ Clin Invest20081183478349010.1172/JCI32460188024962542885
– reference: TakahashiYProtective immunity afforded by inactivated H5N1 (NIBRG-14) vaccine requires antibodies against both hemagglutinin and neuraminidase in miceJ Infect Dis2009199162916371:CAS:528:DC%2BD1MXmvVOmur4%3D10.1086/59895419385735
– reference: WuJSafety and effectiveness of a 2009 H1N1 vaccine in BeijingN Engl J Med2010363241624231:CAS:528:DC%2BC3cXhsF2ltb7N10.1056/NEJMoa100673621158658
– reference: GreenbergMEResponse to a monovalent 2009 influenza A (H1N1) vaccineN Engl J Med2009361240524131:CAS:528:DC%2BD1MXhsFKisr7P10.1056/NEJMoa090741319745216
– reference: ScherlePAGerhardWFunctional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutininJ Exp Med1986164111411281:CAS:528:DyaL28XlvV2jtLw%3D10.1084/jem.164.4.11142944982
– reference: MoiseLT cell epitope redundancy: cross-conservation of the TCR face between pathogens and self and its implications for vaccines and autoimmunityExpert Rev Vaccines2016156076171:CAS:528:DC%2BC28XisFKgurY%3D10.1586/14760584.2016.112309826588466
– volume: 118
  start-page: 3478
  year: 2008
  ident: 1372_CR18
  publication-title: J Clin Invest
  doi: 10.1172/JCI32460
– volume: 181
  start-page: 5306
  year: 2008
  ident: 1372_CR35
  publication-title: J Immunol
  doi: 10.4049/jimmunol.181.8.5306
– volume: 401
  start-page: 708
  year: 1999
  ident: 1372_CR37
  publication-title: Nature
  doi: 10.1038/44385
– volume: 19
  start-page: 20838
  issue: 25
  year: 2014
  ident: 1372_CR43
  publication-title: Eurosurveillance
  doi: 10.2807/1560-7917.ES2014.19.25.20838
– volume: 289
  start-page: 373
  year: 1981
  ident: 1372_CR3
  publication-title: Nature
  doi: 10.1038/289373a0
– volume: 33
  start-page: e81
  year: 2010
  ident: 1372_CR30
  publication-title: Comp Immunol Microbiol Infect Dis
  doi: 10.1016/j.cimid.2010.02.006
– volume: 115
  start-page: 3051
  year: 2010
  ident: 1372_CR38
  publication-title: Blood
  doi: 10.1182/blood-2009-08-239145
– volume: 312
  start-page: 1409
  year: 2014
  ident: 1372_CR23
  publication-title: JAMA
  doi: 10.1001/jama.2014.12854
– volume: 84
  start-page: 3312
  year: 2010
  ident: 1372_CR14
  publication-title: J Virol
  doi: 10.1128/JVI.02226-09
– volume: 11
  start-page: 2241
  year: 2015
  ident: 1372_CR28
  publication-title: Hum Vaccin Immunother
  doi: 10.1080/21645515.2015.1052197
– volume: 361
  start-page: 2414
  year: 2009
  ident: 1372_CR10
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0908535
– volume: 367
  start-page: 1657
  year: 2006
  ident: 1372_CR21
  publication-title: Lancet
  doi: 10.1016/s0140-6736(06)68656-x
– volume: 333
  start-page: 43
  year: 2009
  ident: 1372_CR5
  publication-title: Curr Top Microbiol Immunol
  doi: 10.1007/978-3-540-92165-3_3
– volume: 375
  start-page: 41
  year: 2010
  ident: 1372_CR9
  publication-title: Lancet
  doi: 10.1016/s0140-6736(09)62026-2
– volume: 15
  start-page: S1
  issue: Suppl 4
  year: 2014
  ident: 1372_CR41
  publication-title: BMC bioinformatics
  doi: 10.1186/1471-2105-15-s4-s1
– volume: 9
  start-page: 1577
  year: 2013
  ident: 1372_CR47
  publication-title: Hum Vaccin Immunother
  doi: 10.4161/hv.24615
– volume: 212
  start-page: 1709
  year: 2015
  ident: 1372_CR49
  publication-title: J Exp Med
  doi: 10.1084/jem.20142284
– volume: 185
  start-page: 4998
  year: 2010
  ident: 1372_CR13
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1001395
– volume: 109
  start-page: 2485
  year: 2012
  ident: 1372_CR50
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1115369109
– volume: 363
  start-page: 2416
  year: 2010
  ident: 1372_CR11
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1006736
– volume: 196
  start-page: 4172
  year: 2016
  ident: 1372_CR6
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1600046
– volume: 42
  start-page: 1782
  year: 2004
  ident: 1372_CR31
  publication-title: J Clin Microbiol
  doi: 10.1128/jcm.42.4.1782-1784.2004
– volume: 164
  start-page: 1114
  year: 1986
  ident: 1372_CR34
  publication-title: J Exp Med
  doi: 10.1084/jem.164.4.1114
– volume: 15
  start-page: 607
  year: 2016
  ident: 1372_CR40
  publication-title: Expert Rev Vaccines
  doi: 10.1586/14760584.2016.1123098
– ident: 1372_CR33
  doi: 10.1126/scitranslmed.3008761
– volume: 237
  start-page: 104
  year: 2010
  ident: 1372_CR36
  publication-title: Immunol Rev
  doi: 10.1111/j.1600-065X.2010.00939.x
– volume: 9
  start-page: 1598
  year: 2013
  ident: 1372_CR46
  publication-title: Hum Vaccin Immunother
  doi: 10.4161/hv.25598
– volume: 10
  start-page: 256
  year: 2014
  ident: 1372_CR27
  publication-title: Hum Vaccin Immunother
  doi: 10.4161/hv.28135
– volume: 21
  start-page: 1153
  year: 2014
  ident: 1372_CR25
  publication-title: Clin Vaccine Immunol
  doi: 10.1128/CVI.00272-14
– volume: 22
  start-page: 623
  year: 2014
  ident: 1372_CR44
  publication-title: Trends Microbiol
  doi: 10.1016/j.tim.2014.08.008
– volume: 199
  start-page: 1629
  year: 2009
  ident: 1372_CR48
  publication-title: J Infect Dis
  doi: 10.1086/598954
– volume: 69
  start-page: 531
  year: 2000
  ident: 1372_CR4
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev.biochem.69.1.531
– volume: 11
  start-page: 2312
  year: 2015
  ident: 1372_CR45
  publication-title: Hum Vaccin Immunother
  doi: 10.1080/21645515.2015.1061159
– volume: 88
  start-page: 476
  year: 2008
  ident: 1372_CR29
  publication-title: Int J Hematol
  doi: 10.1007/s12185-008-0215-z
– volume: 18
  start-page: 274
  year: 2012
  ident: 1372_CR17
  publication-title: Nat Med
  doi: 10.1038/nm.2612
– volume: 361
  start-page: 2405
  year: 2009
  ident: 1372_CR7
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0907413
– volume: 28
  start-page: 8258
  year: 2010
  ident: 1372_CR15
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2010.10.077
– volume: 354
  start-page: 1277
  year: 1999
  ident: 1372_CR2
  publication-title: Lancet
  doi: 10.1016/s0140-6736(99)01241-6
– volume: 121
  start-page: 29
  year: 2013
  ident: 1372_CR39
  publication-title: Blood
  doi: 10.1182/blood-2012-07-409755
– volume: 369
  start-page: 2564
  year: 2013
  ident: 1372_CR32
  publication-title: N Engl J Med
  doi: 10.1056/NEJMc1313186
– volume: 207
  start-page: 297
  year: 2013
  ident: 1372_CR16
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jis684
– volume: 180
  start-page: 1758
  year: 2008
  ident: 1372_CR19
  publication-title: J Immunol
  doi: 10.4049/jimmunol.180.3.1758
– volume: 212
  start-page: 86
  year: 2015
  ident: 1372_CR20
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiu662
– volume: 354
  start-page: 1343
  year: 2006
  ident: 1372_CR22
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa055778
– ident: 1372_CR1
– volume: 375
  start-page: 56
  year: 2010
  ident: 1372_CR8
  publication-title: Lancet
  doi: 10.1016/s0140-6736(09)62003-1
– volume: 7
  start-page: e49704
  year: 2012
  ident: 1372_CR26
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0049704
– volume: 62
  start-page: 48
  year: 2015
  ident: 1372_CR42
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2014.08.026
– volume: 20
  start-page: 192
  year: 2014
  ident: 1372_CR24
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid2002.131094
– volume: 106
  start-page: 20365
  year: 2009
  ident: 1372_CR12
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0911580106
– reference: 10520648 - Lancet. 1999 Oct 9;354(9186):1277-82
– reference: 25104221 - BMC Bioinformatics. 2014;15 Suppl 4:S1
– reference: 23239968 - PLoS One. 2012;7(12):e49704
– reference: 2944982 - J Exp Med. 1986 Oct 1;164(4):1114-28
– reference: 25492919 - J Infect Dis. 2015 Jul 1;212(1):86-94
– reference: 26324444 - J Exp Med. 2015 Sep 21;212(10):1709-23
– reference: 19385735 - J Infect Dis. 2009 Jun 1;199(11):1629-37
– reference: 21050903 - Vaccine. 2010 Dec 6;28(52):8258-67
– reference: 25157982 - J Hepatol. 2015 Jan;62(1):48-55
– reference: 19846844 - N Engl J Med. 2009 Dec 17;361(25):2414-23
– reference: 16714186 - Lancet. 2006 May 20;367(9523):1657-64
– reference: 20299097 - Comp Immunol Microbiol Infect Dis. 2010 Dec;33(6):e81-8
– reference: 19745216 - N Engl J Med. 2009 Dec 17;361(25):2405-13
– reference: 10537110 - Nature. 1999 Oct 14;401(6754):708-12
– reference: 27053762 - J Immunol. 2016 May 15;196(10):4172-84
– reference: 18209073 - J Immunol. 2008 Feb 1;180(3):1758-68
– reference: 19039627 - Int J Hematol. 2008 Dec;88(5):476-82
– reference: 25264312 - Trends Microbiol. 2014 Nov;22(11):623-31
– reference: 26588466 - Expert Rev Vaccines. 2016 May;15(5):607-17
– reference: 10966468 - Annu Rev Biochem. 2000;69:531-69
– reference: 24525618 - Hum Vaccin Immunother. 2014;10(2):256-62
– reference: 24993556 - Euro Surveill. 2014 Jun 26;19(25):null
– reference: 24943383 - Clin Vaccine Immunol. 2014 Aug;21(8):1153-63
– reference: 6162101 - Nature. 1981 Jan 29;289(5796):373-8
– reference: 22286307 - Nat Med. 2012 Jan 29;18(2):274-80
– reference: 18802496 - J Clin Invest. 2008 Oct;118(10 ):3478-90
– reference: 20889549 - J Immunol. 2010 Nov 1;185(9):4998-5002
– reference: 20018364 - Lancet. 2010 Jan 2;375(9708):56-66
– reference: 16571878 - N Engl J Med. 2006 Mar 30;354(13):1343-51
– reference: 15071049 - J Clin Microbiol. 2004 Apr;42(4):1782-4
– reference: 25291577 - JAMA. 2014 Oct 8;312(14):1409-19
– reference: 24447423 - Emerg Infect Dis. 2014 Feb;20(2):192-200
– reference: 20727032 - Immunol Rev. 2010 Sep;237(1):104-16
– reference: 24786323 - Sci Transl Med. 2014 Apr 30;6(234):234ra55
– reference: 26090577 - Hum Vaccin Immunother. 2015;11(9):2241-52
– reference: 21158658 - N Engl J Med. 2010 Dec 16;363(25):2416-23
– reference: 26155959 - Hum Vaccin Immunother. 2015;11(9):2312-21
– reference: 23148285 - J Infect Dis. 2013 Jan 15;207(2):297-305
– reference: 20071564 - J Virol. 2010 Apr;84(7):3312-9
– reference: 19918065 - Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20365-70
– reference: 20018365 - Lancet. 2010 Jan 2;375(9708):41-8
– reference: 18832686 - J Immunol. 2008 Oct 15;181(8):5306-12
– reference: 23043072 - Blood. 2013 Jan 3;121(1):29-37
– reference: 23846304 - Hum Vaccin Immunother. 2013 Jul;9(7):1598-607
– reference: 22308386 - Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2485-90
– reference: 24224560 - N Engl J Med. 2013 Dec 26;369(26):2564-6
– reference: 19768400 - Curr Top Microbiol Immunol. 2009;333:43-82
– reference: 20139096 - Blood. 2010 Apr 15;115(15):3051-7
– reference: 23584251 - Hum Vaccin Immunother. 2013 Jul;9(7):1577-86
SSID ssj0000529419
Score 2.3638062
Snippet Influenza vaccines of H7N9 subtype are consistently less immunogenic in humans than vaccines developed for other subtypes. Although prior immunoinformatic...
Abstract Influenza vaccines of H7N9 subtype are consistently less immunogenic in humans than vaccines developed for other subtypes. Although prior...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1283
SubjectTerms 13/1
631/250/255/2514
631/250/590/2294
64/60
82/80
Amino acids
Amino Acids - genetics
Amino Acids - immunology
Animal models
Animals
Antibodies, Viral - immunology
Disease Models, Animal
Epitopes
Epitopes, T-Lymphocyte - genetics
Epitopes, T-Lymphocyte - immunology
Genomes
Hemagglutinins
Humanities and Social Sciences
Humans
Immunogenicity
Immunogenicity, Vaccine
Immunoglobulin G
Influenza
Influenza A Virus, H3N2 Subtype - immunology
Influenza A Virus, H7N9 Subtype - immunology
Influenza Vaccines - immunology
Influenza, Human - immunology
Lymphocytes T
Mice, Inbred BALB C
multidisciplinary
Mutation
Science
Science (multidisciplinary)
Vaccines
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEB9kQfAifltdJYI3Ldt8N8dVXB4e9uTC4iUkaYKFtZXtU9n9652kfY_3_Lx4bdIyZGY6v2EmvwF46WmSLPmmZom7WlDN0edMrJNChXuX8J9Y2D5P1epMvD-X5zujvnJP2EwPPB_ckTSsa1IMkodWtCJ4TBiCSzJGJVkrC9k2xrydZGpm9WZGULPckml4ezRhpMq3yWjutOQaM7C9SFQI-3-HMn9tlvypYloC0ckduL0gSHI8S34XbsThHtycZ0pe3YePx6TM3euvY0dyXh9JmXZD-m5uDIoTQccl7nM_jMSFvpsIAldyMX4nfb4sMqJJ9QHBORkTWelTQ765kMvv0wM4O3n34e2qXgYo1AGB2LpOGO2TCUlH3cWQktGBxla4LjrlHcaljgnnnWcsSanRdSVzpgnKeaE9Zhr8IRwM4xAfA1Gp9RThmneIYZRiJhqnBH6ONx2qO1ZAN4dpw8IunodcXNhS5eatnRVgUQG2KMDKCl5t3_kyc2v8dfebrKPtzsyLXR6gtdjFWuy_rKWCw42G7eKsk6V56k1mXqUVvNguo5vl2okbIqrKUsR1mEorZSp4NBvEVhKM8FJK1lSg90xlT9T9laH_VKi8peCYU_IKXm-MakesPx7Fk_9xFE_hFiveIGrWHsLB-vJrfIYAa-2fF1_6Ad1sIIk
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Jb9UwELagCIkLYidQkJG4QdR4j0-oIKonDj1R6YmL5RUitUlpHiD49YydvMBj6TWbHH8znm884xmEnjuSBE2uqWlituZEMdA5HeskAXBnE6yJpdrnsVyd8HdrsZ433MY5rXK7JpaFOgw-75EfkNyaJJfHJK_OP9e5a1SOrs4tNK6ia7l0WU7pUmu17LHkKBYnej4r07D2YAR7lc-UkZxvyRT4YTv2qJTt_xfX_Dtl8o-4aTFHR7fQzZlH4sMJ-NvoSuzvoOtTZ8nvd9GHQ1y673U_YsDZu4-49LzBXZjSg-KIQX2xPev6AVvfhREDfcWnwzfc5SMjAwhW54Gi4yHhlTrW-Kv1OQg_3kMnR2_fv1nVcxuF2gMd29QJbH7SPqmoQvQpaeVJbLkN0UpnwToFyq2zjtIkhAIFFtTqxkvruHLgb7D7aK8f-vgQYZlaR4C0OQtMRkqqo7aSw-dYEwD0WCGynUzj5xrjudXFqSmxbtaaCQADAJgCgBEVerG8cz5V2Lj06dcZo-XJXB27XBguPppZ2YzQNDQpesF8y1vuHTiZ3sL4ohS0FbJC-1uEzayyo_klYBV6ttwGZcsRFNtHgMoQYHfgUEupK_RgEohlJGDnhRC0qZDaEZWdoe7e6btPpaC34Aw8S1ahl1uh-m1Y_52KR5f_xWN0gxY55zVt99He5uJLfAIEauOeFi35CTpcF8o
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature Link
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VIiQuiDeBgozEDSLiZ-JjWVGtOPREpYqLZTs2RCpJ1V2oyq9n7DzEQkHimtjRKDOT-SYz_gbglaNRsuiqkkVuS0Frjj6nQxkVKtzZiN_EzPZ5rNYn4sOpPN0DNp-FyU37mdIyf6bn7rC3Gww06TAYTY2SvMYE6gbcTNTtyapXarX8V0mVK0H1dD6m4s01W3diUKbqvw5f_tkm-VutNIego7twZ8KO5HCU9h7shf4-3BqnSV49gE-HJE_c636ElqSMPpA854Z07dgSFDYEXZbYr10_EOu7dkMQspKz4ZJ06ZjIgMbUeYTlZIhkXR9r8t36VHjfPISTo_cfV-tyGp1QeoRg2zJinI_axzrUbfAx6trT0AjbBqucxYjUMmGddYxFKWt0WsmsrryyTtQOcwz-CPb7oQ9PgKjYOIpAzVlEL0oxHbRVAh_HqxYVHQqg88s0fuIVT-Mtzkyub_PGjAowqACTFWBkAa-XPecjq8Y_V79LOlpWJkbsfGG4-GwmCzFSs7aKwUvuG9EI7zCx9BblC0qyRqoCDmYNm8lNN4ameTeJc5UW8HK5jQ6Wqia2D6gqQxHRYRKtlC7g8WgQiyQY26WUrCqg3jGVHVF37_Tdl0ziLQXHbJIX8GY2ql_E-uurePp_y5_BbZbtXpSsOYD97cW38BxB1Na9yF7zE5PRFZ4
  priority: 102
  providerName: Springer Nature
Title A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines
URI https://link.springer.com/article/10.1038/s41598-017-01372-5
https://www.ncbi.nlm.nih.gov/pubmed/28455520
https://www.proquest.com/docview/1961811091
https://www.proquest.com/docview/1893549669
https://pubmed.ncbi.nlm.nih.gov/PMC5430863
https://doaj.org/article/592d0fec53c8484cb924caf5ee652856
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dq9MwFD_cDwRfxG-r1xHBN62uaT7aB5HdcS9j4BB1MHwpSZpcC7PVbX5c_3pP0nY4nYJPhaYNIeecnt9pkt8P4LFOHKdOD2PqUhWzRKYYc7mNnUCDa-XwmxjYPmdiMmfTBV8cQC931E3gem9p5_Wk5qvls--fL19iwL9oj4xnz9eYhPxBscRvokwlFleHcIyZSfpAfdXB_Zbrm-YsaH14EvYYwQTtztHs72YnVwVK_3049M_tlL-tqYZUdX4drnUYk4xap7gBB7a-CVda1cnLW_B-RIIyX_XDlsRX_pYEPRxSle3WIbsmGNpEfazqhihTlWuC0JYsm2-k8sdJGnS6yiB8J40jEznLyVdl_AL9-jbMz8_ejSdxJ7EQG4Rqm9ghHnC5cdLK0hrncmkSmzFVWiW0wsxVUqa00pQ6ziUGN6cqHxqhNJMaa5H0DhzVTW3vAREu0wkCOq0Q5QhBc5srwbC7dFiiQ9gIkn4yC9Pxj3sZjGUR1sHTrGgNUKABimCAgkfwZPvOp5Z9459Pn3obbZ_0zNnhRrO6KLpALHhOy6GzhqcmYxkzGgtQo3B8VnCacRHBSW_hovfGIvG6OJ6bNYng0bYZA9GvrqjaoqmKBJEfFttC5BHcbR1iOxLEAJxzOoxA7rjKzlB3W-rqQyD75izFqjON4GnvVL8M669Tcf-_Ju4BXKXB7VlMsxM42qy-2IeItTZ6AIdyIQdwPBpN307xeno2e_0G747FeBD-XwxCiP0EY_0mfQ
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrRBcEG8CBYwEJ4ia-JXkgFALrba0rBBqpYqLsR0bIpWkNIWq_Ch-I-M8FpZHb73GieV4vhl_47FnAB6b1AvqTRJTz3TM04yhzhUu9hIFbrRHm9hl-5zJ6R5_vS_2l-DHeBcmHKscbWJnqMvGhj3y1TSUJgnpMdMXh1_iUDUqRFfHEho9LLbd6Qm6bO3zrVco3yeUbm7svpzGQ1WB2CI7OY49LoG-sD5zWems90VmU5dzXTotjUZjXVKujTaUeiEyxLOgukis1IZnBuk3w34vwDJn6MpMYHl9Y_b23XxXJ8TNeFoMt3MSlq-2uEKGW2xpOOHJMvT8FlbArlDAv9jt34c0_4jUdgvg5lW4MjBXstZD7Rosufo6XOxrWZ7egPdrpKv3V313JQn7CY50VXZIVfYHklxL0GAQ_bmqG6JtVbYECTM5aE5IFS6pNAjlyqJTQBpPptmsIN-0DWH_9ibsncsU34JJ3dTuDhDpc5MiTTQauZOUtHCFlhy7Y0mJMHMRpONkKjtkNQ_FNQ5UF11nueoFoFAAqhOAEhE8nX9z2Of0OPPt9SCj-ZshH3f3oDn6qAb1VqKgZeKdFczmPOfWoFtrNY7PSUFzISNYGSWsBiPRql-QjuDRvBnVO8RsdO1QVCpFPokuvJRFBLd7QMxHgsxCCEGTCLIFqCwMdbGlrj51KcQFZ-jLsgiejaD6bVj_nYq7Z__FQ7g03X2zo3a2Ztv34DLtMM9jmq_A5Pjoq7uP9O3YPBh0hsCH81bTn5LkV90
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYgL4k2ggJHgBNHGdmwnB4QKZbWlaMWBSisuxnZsiFSS0ixU5afx6xg7ycLy6K3XvOR4vhl_4xnPIPTIEM-pN1lKPdNpTiQDnStd6gUI3GgPNjFW-5yL2X7-esEXG-jHeBYmpFWONjEa6qq1YY98QkJrklAek0z8kBbxdmf6_PBLGjpIhUjr2E6jh8ieOzkG9617trsDsn5M6fTVu5ezdOgwkFpgKsvUw3LoS-ulk5Wz3pfSElfkunJaGA2Gu6K5NtpQ6jmXgG1OdZlZoU0uDVBxBt89h85LxknQMbmQq_2dEEHLSTmc08lYMelgrQzn2UjI9WQSfMC1tTC2DPgXz_07XfOPmG1cCqdX0OWBw-LtHnRX0YZrrqELfVfLk-vo_TaOnf_q767CYWfB4dhvB9dVn5rkOgymA-vPddNibeuqw0Cd8UF7jOtwXKUFUNcW3APcejyT8xJ_0zYkAHQ30P6ZTPBNtNm0jbuNsPCFIUAYjQYWJQQtXalFDp9jWQWAcwki42QqO9Q3D202DlSMs7NC9QJQIAAVBaB4gp6s3jnsq3uc-vSLIKPVk6Eyd7zQHn1Ug6IrXtIq885yZou8yK0BB9dqGJ8TnBZcJGhrlLAazEWnfoE7QQ9Xt0HRQ_RGNw5EpQgwS3DmhSgTdKsHxGokwDE45zRLkFyDytpQ1-809adYTJznDLxalqCnI6h-G9Z_p-LO6X_xAF0E5VRvdud7d9ElGiGfp7TYQpvLo6_uHvC4pbkfFQajD2etoT8BvDtarQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+humanized+mouse+model+identifies+key+amino+acids+for+low+immunogenicity+of+H7N9+vaccines&rft.jtitle=Scientific+reports&rft.au=Wada%2C+Yamato&rft.au=Nithichanon%2C+Arnone&rft.au=Nobusawa%2C+Eri&rft.au=Moise%2C+Leonard&rft.date=2017-04-28&rft.issn=2045-2322&rft.eissn=2045-2322&rft.volume=7&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-017-01372-5&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s41598_017_01372_5
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon